Pathogen Inactivation: Mechanisms of Action and in vitro Efficacy of Various Agents
- 1 August 2002
- journal article
- review article
- Published by Wiley in Vox Sanguinis
- Vol. 83 (s1) , 267-270
- https://doi.org/10.1111/j.1423-0410.2002.tb05315.x
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Pathogen inactivation of red cell concentrates using Inactine™ chemistryTransfusion and Apheresis Science, 2001
- The rationale for pathogen inactivation treatment of platelet components—IntroductionSeminars in Hematology, 2001
- Fundamentals of the psoralen-based Helinx™ technology for inactivation of infectious pathogens and leukocytes in platelets and plasmaSeminars in Hematology, 2001
- Duck Hepatitis B Virus Inactivation and 8-Methoxypsoralen Photoadduct Formation in Human Platelet ConcentratesPhotochemistry and Photobiology, 1998
- Photosensitized Inactivation of Plasmodium falciparum‐ and Babesia divergens‐Infected Erythrocytes in Whole Blood by Lipophilic Pheophorbide DerivativesVox Sanguinis, 1997
- Virally Inactivated Fresh Frozen PlasmaVox Sanguinis, 1995
- Hypericin as an inactivator of infectious viruses in blood componentsTransfusion, 1995
- Inactivation of free and cell‐associated human immunodeficiency virus in platelet suspensions by aminomethyltrimethylpsoralen and ultraviolet lightTransfusion, 1994
- Virucidal levels of ozone induce hemolysis and hemoglobin degradationTransfusion, 1991
- Transmission of Hepatitis B Virus Infection by Transfusion of Frozen-Deglycerolized Red Blood CellsNew England Journal of Medicine, 1978